← Back to Search

Other

Cooling Vest for Hyperthermia in Spinal Cord Injury

N/A
Recruiting
Led By John Philip Handrakis, PT DPT EdD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Spinal cord injury (SCI) >1 year in duration
Gender and age-matched (±5 years) able-bodied (AB) controls
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (0 min) and end of thermal challenge (120 min) will be compared
Awards & highlights

Study Summary

This trial is testing a "smart" cooling vest that will help people with high spinal cord injuries keep their core temperature within a normal range when exposed to warm temperatures.

Who is the study for?
This trial is for individuals with spinal cord injuries above the 6th thoracic vertebrae and have had their condition for over a year. It's also open to able-bodied people of similar age as controls. Participants should not have cardiovascular, kidney, or severe thyroid diseases; traumatic brain injury; acute illness; be pregnant; or have certain other medical conditions.Check my eligibility
What is being tested?
The study is testing a 'smart' cooling vest designed to help persons with high-level spinal cord injuries regulate their body temperature in warm environments. The goal is for the vest to reduce core body temperature increases by at least half during heat exposure.See study design
What are the potential side effects?
While specific side effects are not listed, potential risks may include skin irritation from wearing the vest, discomfort due to cold temperatures, and possible malfunctioning of the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a spinal cord injury for over a year.
Select...
I am within 5 years of age of the patient and do not have any disabilities.
Select...
My spinal cord injury is between C4 and T2 and is classified as severe.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (0 min) and end of thermal challenge (120 min) will be compared
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (0 min) and end of thermal challenge (120 min) will be compared for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Skin temperature (Tsk) change
Thermal Sensation (TS) change
Secondary outcome measures
Core body temperature (Tcore) change
Thermal comfort (TC) change

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Arm 2: Cooling VestExperimental Treatment1 Intervention
Phase 2: Participants with Hi-SCI will wear the wet vest (experimental condition) in a warm thermal chamber (35°C) for up to 2 hours in the seated position, to determine: (1) change in Tcore and (2) perception of heat and thermal comfort.
Group II: Arm 1: Cooling VestExperimental Treatment1 Intervention
Phase 1: After satisfying bench testing criteria, AB participants will wear the wet cooling vest at maximal settings for 2 hours in the seated position in a warm thermal chamber (35°C), to determine: (1) minimum skin temperatures beneath the cooling vest and (2) subjective thermal sensation of their skin beneath the cooling vest.
Group III: Arm 3: No VestActive Control1 Intervention
Phase 2: Participants with Hi-SCI will wear no vest (control condition) in a warm thermal chamber (35°C) for up to 2 hours in the seated position, to determine: (1) change in Tcore and (2) perception of heat and thermal comfort.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cooling Vest
2017
N/A
~40

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Spinal Cord Injury (SCI) include interventions that help manage body temperature, such as the Smart Cooling Vest, which dissipates body heat to prevent hyperthermia. This is crucial for patients with high-level SCI (above the 6th thoracic vertebrae) who cannot regulate their core body temperature effectively. Other treatments include physical therapy to improve mobility and strength, functional electrical stimulation to enhance muscle function, and pharmacologic treatments targeting pain and spasticity. These treatments are essential for improving the quality of life, preventing complications, and enabling participation in daily activities for SCI patients.
Overview of Cochrane Systematic Reviews for Rehabilitation Interventions in Persons With Spinal Cord Injury: A Mapping Synthesis.Physical therapy treatment of a pediatric patient with symptoms consistent with a spinal cord injury without radiographic abnormality: A retrospective case report.No Difference Between Noxious and Innocuous Thermal Stimulation on Motor Recovery of Upper Extremity in Patients With Acute Stroke: A Randomized Controlled Trial With 6-Month Follow-up.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,621 Previous Clinical Trials
3,323,486 Total Patients Enrolled
John Philip Handrakis, PT DPT EdDPrincipal InvestigatorJames J. Peters Veterans Affairs Medical Center
2 Previous Clinical Trials
58 Total Patients Enrolled

Media Library

Cooling Vest (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05441449 — N/A
Spinal Cord Injury Research Study Groups: Arm 2: Cooling Vest, Arm 1: Cooling Vest, Arm 3: No Vest
Spinal Cord Injury Clinical Trial 2023: Cooling Vest Highlights & Side Effects. Trial Name: NCT05441449 — N/A
Cooling Vest (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05441449 — N/A
~6 spots leftby Oct 2024